Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis

IFN-γ and IL-22 are deeply involved in the pathogenesis of psoriasis, as they boost the expression of inflammatory genes and alter proliferative and differentiative programs in keratinocytes. The JAK1/JAK2/STAT1 and JAK1/TYK2/STAT3 pathways triggered by IFN-γ and IL-22, respectively, are aberrantly...

Descripción completa

Detalles Bibliográficos
Autores principales: Morelli, Martina, Scarponi, Claudia, Mercurio, Laura, Facchiano, Francesco, Pallotta, Sabatino, Madonna, Stefania, Girolomoni, Giampiero, Albanesi, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276416/
https://www.ncbi.nlm.nih.gov/pubmed/30581877
http://dx.doi.org/10.1155/2018/7897263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276416/
https://www.ncbi.nlm.nih.gov/pubmed/30581877
http://dx.doi.org/10.1155/2018/7897263

Ejemplares similares